Consensus SynBiotic SE

Equities

SBX

DE000A3E5A59

Real-time Estimate Tradegate Other stock markets 11:39:18 2024-05-10 am EDT			5-day change	1st Jan Change
9.1 ^EUR	-1.09%		-3.97%	+207.69%

May. 09	Medical Cannabis Group SynBiotic Buys Local Peer Weeco Pharma	MT
Apr. 23	SynBiotic Boosts CBD Business with Ilesol Pharmaceuticals Takeover	MT

Evolution of the average Target Price on SynBiotic SE

Price target over the last 5 years

History of analyst recommendation changes

694dc02cc86040f40fb6f175.F32sYI-FYPCLxkMOaZgMvZQdT9R1X-D1q87TWTmhL-E.ZVDPLs7TL7_ak3Q-BM470tpMLosgFaWDyLSbFm_VYrdZJMUvxbAKnLixJA~00f34cb77bb3199b449e536c3b2d24b9

Analyst Recommendations on SynBiotic SE

Synbiotic share price fireworks continue - cannabis approval imminent

Feb. 23

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.2 EUR

Average target price

15.2 EUR

Spread / Average Target

+65.22%

High Price Target

15.2 EUR

Spread / Highest target

+65.22%

Low Price Target

15.2 EUR

Spread / Lowest Target

+65.22%

Consensus detail

Consensus revision (last 18 months)

Ratings for SynBiotic SE

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar